Ortho Evra Label Update Includes Study Data On Blood Clot Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA requests J&J conduct longer follow up studies on the risk of serious blood clots, heart attack and stroke associated with the birth control patch.